ABSTRACTPenyakit tuberkulosis merupakan salah satu penyakit dengan prevalensi tinggi di Indonesia. Selama proses pemeriksaan pre-diagnosis hingga pengobatan tuberkulosis, banyak biaya yang dikeluarkan pasien tuberkulosis, mulai dari biaya langsung dan biaya tidak langsung yang dapat berdampak terhadap kondisi ekonomi penderita tuberkulosis. Selain itu, pada penyakit tuberkulosis dapat timbul permasalah berupa resistensi terhadap obat anti-tuberkulosis multi-drug resistance tuberculosis yang membutuhkan regimen pengobatan yang berbeda dengan tuberkulosis sensitif. Penelitian ini bertujuan untuk membandingkan pasien tuberkulosis sensitif dan pasien tuberkulosis resistensi obat pada aspek biaya tidak langsung maupun biaya langsung non-medis. Penelitian ini dilakukan dengan pendekatan cross-sectional, sebanyak 156 pasien tuberkulosis diwawancarai dengan mengunakan kuesioner tentang pembiayaan selama mengalami tuberkulosis. Pada hasil uji statistik diperoleh nilai p pada variabel biaya suplementasi p=0,031 , transportasi pre-diagnosis.
ABSTRACTTuberculosis is one of the disease with high prevalence in Indonesia. Through out the inspection process pre diagnostic to the treatment process of tuberculosis, the patients need to spend a lot of money for the costs, consist of the direct costs and indirect costs that may have an impact for the patients rsquo economic conditions. In addition, many problem may arise in the form of resistance to anti tuberculosis drugs multi drug resistance which require another treatment regimens. The aim of this study is to compare between drug sensitive tuberculosis patients and multi drug resistance tuberculosis patients in the aspect of indirect and direct non medical cost. This research was conducted in a cross sectional model and 156 tuberculosis patients were interviewed by using a questionnaire to know their financing during tuberculosis treatment process. In the statistical test, p values was obtained for different variables, consist of cost supplementation p 0.031, transportation during pre diagnostic phase.